|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/26 | |
| C07K 14/605 |
| (11) | Patento numeris | 3129041 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15713772.0 |
| Europos patento paraiškos padavimo data | 2015-04-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-02-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-06-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2015/057442 |
| Data | 2015-04-07 |
| (87) | Numeris | WO 2015/155151 |
| Data | 2015-10-15 |
| (30) | Numeris | Data | Šalis |
| 14163697 | 2014-04-07 | EP |
| (72) |
LINDEROTH, Lars, DK
KOFOED, Jacob, DK
LAU, Jesper, DK
BLOCH, Paw, DK
GARIBAY, Patrick William, DK
KODRA, Jįnos Tibor, DK
|
| (73) |
Novo Nordisk A/S,
Novo Allé, 2880 Bagsvęrd,
DK
|
| (54) | DOUBLE-ACYLATED GLP-1 COMPOUNDS |
| DOUBLE-ACYLATED GLP-1 COMPOUNDS |